Leder, B. Z., Mitlak, B., Hu, M., Hattersley, G., & Bockman, R. S. (2019). Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis. J Clin Endocrinol Metab.
Stile di citazione ChicagoLeder, Benjamin Z., Bruce Mitlak, Ming-yi Hu, Gary Hattersley, e Richard S. Bockman. "Effect of Abaloparatide Vs Alendronate On Fracture Risk Reduction in Postmenopausal Women With Osteoporosis." J Clin Endocrinol Metab 2019.
Citazione MLALeder, Benjamin Z., et al. "Effect of Abaloparatide Vs Alendronate On Fracture Risk Reduction in Postmenopausal Women With Osteoporosis." J Clin Endocrinol Metab 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.